Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 7/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TEAD1 | P28347 | 2/20 | 0.33 |
| ▸ | PNMT | P11086 | 4/20 | 0.32 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.31 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.31 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.31 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.31 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.31 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.31 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31345984 | 0.85 | PNMT (0.35) | TEAD1PNMTAADAT | |
| SCHEMBL31345963 | 0.82 | TEAD1 (0.42) | TEAD1 | |
| SCHEMBL31346002 | 0.82 | TEAD1 (0.42) | TEAD1 | |
| SCHEMBL31346029 | 0.82 | CYP11B1 (0.40) | CYP11B1CYP11B2GRIN1GRIN2B | |
| SCHEMBL31345979 | 0.81 | CYP11B1 (0.44) | CYP11B1CYP11B2HSD17B10 | |
| SCHEMBL31346022 | 0.81 | FFAR1 (0.39) | TEAD1PNMT | |
| SCHEMBL31346038 | 0.80 | TERT (0.34) | TEAD1PNMT | |
| SCHEMBL31346060 | 0.80 | TERT (0.34) | TEAD1PNMT | |
| SCHEMBL31346045 | 0.78 | TEAD1 (0.37) | TEAD1PNMT | |
| SCHEMBL31346056 | 0.76 | TEAD1 (0.34) | TEAD1PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |